Log in

Bruker Stock Forecast, Price & News

+0.55 (+1.31 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $42.54
50-Day Range
MA: $40.55
52-Week Range
Now: $42.54
Volume463,409 shs
Average Volume688,388 shs
Market Capitalization$6.51 billion
P/E Ratio40.13
Dividend Yield0.38%
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.
Read More
Bruker logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.62 out of 5 stars

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
Current SymbolNASDAQ:BRKR
Phone(978) 663-3660



Sales & Book Value

Annual Sales$2.07 billion
Cash Flow$2.09 per share
Book Value$5.96 per share


Net Income$197.20 million


Market Cap$6.51 billion
Next Earnings Date11/2/2020 (Confirmed)
+0.55 (+1.31 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Bruker (NASDAQ:BRKR) Frequently Asked Questions

How has Bruker's stock price been impacted by COVID-19?

Bruker's stock was trading at $40.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BRKR shares have increased by 6.4% and is now trading at $42.54.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Bruker?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bruker

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Bruker

How can I listen to Bruker's earnings call?

Bruker will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) posted its earnings results on Monday, August, 3rd. The medical research company reported $0.21 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.05 by $0.16. The medical research company had revenue of $424.60 million for the quarter, compared to analysts' expectations of $395.51 million. Bruker had a return on equity of 22.70% and a net margin of 8.35%. The business's revenue for the quarter was down 13.4% compared to the same quarter last year. During the same period last year, the company posted $0.33 earnings per share.
View Bruker's earnings history

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Friday, August 7th. Stockholders of record on Tuesday, September 1st will be paid a dividend of $0.04 per share on Friday, September 18th. This represents a $0.16 annualized dividend and a yield of 0.38%. The ex-dividend date is Monday, August 31st.
View Bruker's dividend history

What price target have analysts set for BRKR?

10 analysts have issued 1 year price targets for Bruker's shares. Their forecasts range from $27.00 to $63.00. On average, they anticipate Bruker's stock price to reach $44.95 in the next twelve months. This suggests a possible upside of 5.7% from the stock's current price.
View analysts' price targets for Bruker

Are investors shorting Bruker?

Bruker saw a decline in short interest in October. As of October 15th, there was short interest totaling 2,490,000 shares, a decline of 19.2% from the September 30th total of 3,080,000 shares. Based on an average trading volume of 467,900 shares, the days-to-cover ratio is presently 5.3 days. Approximately 2.5% of the shares of the stock are short sold.
View Bruker's Short Interest

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), The Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Who are Bruker's key executives?

Bruker's management team includes the following people:
  • Frank H. Laukien, Chairman, President & Chief Executive Officer
  • Gerald N. Herman, CFO, Principal Accounting Officer & VP
  • Mark Robert Munch, Executive Vice President
  • Jürgen Srega, Group President-Bruker CALID Segment
  • Falko Busse, President-Bruker BioSpin Group

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by many different institutional and retail investors. Top institutional investors include Boston Trust Walden Corp (0.39%), Scout Investments Inc. (0.15%), Assenagon Asset Management S.A. (0.14%), Cambiar Investors LLC (0.11%), CWM LLC (0.10%) and State of New Jersey Common Pension Fund D (0.06%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends for Bruker

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including BNP Paribas Arbitrage SA, WINTON GROUP Ltd, CWM LLC, Scout Investments Inc., Lipe & Dalton, and Comerica Bank. Company insiders that have sold Bruker company stock in the last year include Cynthia M Friend, and Marc A Kastner.
View insider buying and selling activity for Bruker

Which institutional investors are buying Bruker stock?

BRKR stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Dupont Capital Management Corp, Boston Trust Walden Corp, Nisa Investment Advisors LLC, Cambiar Investors LLC, State of New Jersey Common Pension Fund D, Cambridge Investment Research Advisors Inc., and Envestnet Asset Management Inc..
View insider buying and selling activity for Bruker

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $42.54.

How big of a company is Bruker?

Bruker has a market capitalization of $6.51 billion and generates $2.07 billion in revenue each year. The medical research company earns $197.20 million in net income (profit) each year or $1.57 on an earnings per share basis. Bruker employs 7,230 workers across the globe.

What is Bruker's official website?

The official website for Bruker is www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at (978) 663-3660 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.